Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Intra-Cellular Therapies Inc. buy melinda

Intra-Cellular Therapies Inc.
Start price
€16.35
30.08.17 / 50%
Target price
€22.55
27.12.17
Performance (%)
-14.01%
End price
€14.06
27.12.17
Summary
This prediction ended on 27.12.17 with a price of €14.06. The prediction for Intra-Cellular Therapies Inc. disappointed with a performance of -14.01%. melinda has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Intra-Cellular Therapies Inc. - - - -
iShares Core DAX® 1.644% 4.865% 25.089% 64.694%
iShares Nasdaq 100 0.747% 2.923% 8.975% 109.729%
iShares Nikkei 225® 2.442% 6.212% 21.408% 55.832%
iShares S&P 500 0.618% 2.843% 5.726% 67.674%

Comments by melinda for this prediction

In the thread Intra-Cellular Therapies Inc. diskutieren
Prediction Buy
Perf. (%) -14.01%
Target price 22.550
Change
Ends at 27.12.17

Therapien



ITCI auf dem richtigen Weg für die Einreichung der NDA bis Mitte 2018



melinda 
0
Report Share
30.08.17
Prediction Buy
Perf. (%) -14.01%
Target price 22.550
Change
Ends at 27.12.17

(Vom Mitglied beendet)

melinda 
0
Report Share
27.12.17

Stopped prediction by melinda for Intra-Cellular Therapies Inc.

buy
Intra-Cellular Therapies Inc.

Start price
Target price
Perf. (%)
€11.81
04.04.19
€18.04
04.11.21
233.36%
05.11.21

melinda 
18.08.19 50%
buy
Intra-Cellular Therapies Inc.

Start price
Target price
Perf. (%)
€18.13
30.08.17
€25.00
27.12.17
-14.01%
27.12.17

melinda 
14.08.19 50%